Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea
© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflicts of Interest
No potential conflict of interest relevant to this article was reported.
Risk subgroup | NIH criteria | AFIP criteria |
---|---|---|
Very low | 4 (5.2) | 36 (46.9) |
Low | 48 (62.3) | 22 (28.6) |
Intermediate/moderate | 9 (11.7) | 12 (15.6) |
High | 16 (20.8) | 7 (9.1) |
Variable | n (%) |
---|---|
Median age (range, yr) | 57 (28-86) |
Gender | |
Female | 28 (36.4) |
Male | 49 (63.6) |
Tumor size (cm) | |
≤2 | 8 (10.4) |
>2 and ≤5 | 52 (67.5) |
>5 and ≤10 | 12 (15.6) |
>10 | 5 (6.5) |
Tumor location | |
Stomach | 54 (70.1) |
Duodenum | 12 (15.6) |
Jejunum/ileum | 10 (13.0) |
Rectum | 1 (1.3) |
Mitosis | |
≤5/50HPFs | 62 (80.5) |
6–10/50HPFs | 4 (5.2) |
>10/50HPFs | 11 (14.3) |
Ki-67 LI (%) | |
≤5 | 59 (76.6) |
6–10 | 10 (13.0) |
>10 | 8 (10.4) |
PHH3 MI | |
≤5/50HPFs | 51 (66.2) |
6–10/50HPFs | 11 (14.3) |
>10/50HPFs | 15 (19.5) |
Risk subgroup | NIH criteria | AFIP criteria |
---|---|---|
Very low | 4 (5.2) | 36 (46.9) |
Low | 48 (62.3) | 22 (28.6) |
Intermediate/moderate | 9 (11.7) | 12 (15.6) |
High | 16 (20.8) | 7 (9.1) |
Patient No. | Sex/Age (yr) | Location | Size | Mitosis | Ki-67 LI | PHH3 MI | Risk of tumor progression (%) |
|
---|---|---|---|---|---|---|---|---|
AFIP criteria | PHH3 MI applied | |||||||
1 | M/51 | Duodenum | 4.5 | 2 | 10 | 14 | Low (8.3) | High (50) |
2 | M/48 | Jejunum | 3.0 | 2 | 4 | 6 | Low (4.3) | High (73) |
3 | M/47 | Ileum | 3.9 | 2 | 8 | 10 | Low (4.3) | High (73) |
4 | M/56 | Rectum | 2.1 | 4 | 3 | 7 | Low (8.5) | High (52) |
5 | M/67 | Stomach | 3.0 | 1 | 4 | 8 | Very low (1.9) | Moderate (16) |
6 | M/57 | Stomach | 2.5 | 2 | 3 | 7 | Very low (1.9) | Moderate (16) |
7 | M/57 | Stomach | 4.5 | 3 | 6 | 6 | Very low (1.9) | Moderate (16) |
8 | F/67 | Stomach | 2.9 | 4 | 5 | 10 | Very low (1.9) | Moderate (16) |
9 | M/64 | Stomach | 2.7 | 5 | 5 | 14 | Very low (1.9) | Moderate (16) |
10 | M/64 | Stomach | 2.2 | 5 | 3 | 6 | Very low (1.9) | Moderate (16) |
GIST, gastrointestinal stromal tumor; HPFs, high power fields; Ki-67 LI, Ki-67 labeling index; PHH3 MI, phosphohistone H3 mitotic index.
Values are presented as number (%). GISTs, gastrointestinal stromal tumors; NIH, National Institutes of Health; AFIP, Armed Forces Institute of Pathology.
PHH3 MI, phosphohistone H3 mitotic index; AFIP, Armed Forces Institute of Pathology; Ki-67 LI, Ki-67 labeling index.